ESR1 and breast cancer: A variety of studies have shown that isoflavones stimulate ER+ human breast cancer cell xenoplants in ovariectomized athymic mice [13,65-68], estrogen-dependent mammary tumors in rats [69], and reproductive tissues in adult female mice [70,71].